Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece Full Text
BMC Dermatology, 07/27/2012
Avgerinou G et al. – The inclusion of ustekinumab in the treatment of moderate to severe psoriasis in Greece is anticipated to have short– and long–term health and economic benefits, both on an annual and per–patient basis.



